Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Number of holders
-
108
-
Total 13F shares, excl. options
-
44,395,070
-
Shares change
-
+9,785,864
-
Total reported value, excl. options
-
$1,093,343,381
-
Value change
-
+$240,851,131
-
Number of buys
-
66
-
Number of sells
-
-27
-
Price
-
$24.63
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q3 2021
117 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q3 2021.
Avidity Biosciences, Inc. - Common Stock (RNA) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44,395,070 shares
of 149,544,182 outstanding shares and own 29.69% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7,090,650 shares), RTW INVESTMENTS, LP (4,795,000 shares), FMR LLC (3,833,667 shares), BlackRock Inc. (3,212,776 shares), EcoR1 Capital, LLC (2,759,505 shares), FEDERATED HERMES, INC. (2,475,900 shares), Cormorant Asset Management, LP (2,162,115 shares), VANGUARD GROUP INC (1,942,613 shares), Avidity Partners Management LP (1,645,000 shares), and STATE STREET CORP (1,429,004 shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.